BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Avineuro 

6605 Nancy Ridge Drive
Suite 126
San Diego  California  92121  U.S.A.
Phone: 858-436-1537 Fax: 858-228-9798


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Avineuro Announces Beginning of Phase 2b Clinical Studies of AVN-211, Potent Small Molecule for Treatment of Schizophrenia 7/15/2013 10:12:03 AM    More...
Avineuro Reports Positive Phase 2a Clinical Proof of Concept Trial Results on AVN-211, Potent Small Molecule for Treatment of Schizophrenia 2/22/2011 9:09:44 AM    More...
Avineuro Reports Positive Phase I Clinical Trial Results On AVN-322, Potent Small Molecule For Treatment Of Alzheimer’s Disease 3/1/2010 11:48:34 AM    More...
Avineuro Announces Beginning Of Phase II Clinical Studies Of AVN-101, Potent Small Molecule For Treatment Of Alzheimer's Disease And Anxiety 2/2/2010 12:11:24 PM    More...
Avineuro Reports Positive Phase I Clinical Trial Results on AVN-101, Potent Small Molecule for Treatment of Alzheimer’s Disease 10/27/2009 12:20:35 PM    More...
Clinical Development Milestones Achieved for Avineuro CNS Collaboration with ChemDiv, Inc. 9/16/2009 11:02:16 AM    More...
Avineuro Announces Beginning Of Phase II Clinical Studies Of AVN-397, Potent Small Molecule For Treatment Of Anxiety And Alzheimer's Disease 6/23/2009 11:50:25 AM    More...
Avineuro Announces Beginning Of Phase I Clinical Studies Of AVN-322, Potent Small Molecule For Treatment Of Alzheimer's Disease 6/16/2009 11:48:07 AM    More...
Avineuro Announces Beginning Of Phase II Clinical Studies Of AVN-211, Potent Small Molecule For Treatment Of Schizophrenia 6/10/2009 8:18:26 AM    More...
Avineuro Reports Positive Phase I Clinical Trial Results On AVN-211, Potent Small Molecule For Treatment Of Schizophrenia 5/19/2009 1:30:24 PM    More...
12